In 2009, the group identified 2, 003 drug-counterfeiting incidents world-wide, based on law-enforcement actions, regulators' warnings and company announcements that fake drugs had been discovered.
This post is brought to you by PaRR (Policy and Regulatory Report) a product of The Mergermarket Group providing proprietary intelligence and research on competition law and sector-specific regulatory changes around the world.